Literature DB >> 12462404

Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders.

Julie Pongrac, Frank A Middleton, David A Lewis, Pat Levitt, Károly Mirnics.   

Abstract

DNA microarray transcriptome profiling of the postmortem brain opens novel horizons in understanding molecular changes associated with complex psychiatric disorders. With careful analysis and interpretation of microarray data we are uncovering previously unknown, expression patterns that maybe subject-specific and pivotal in understanding the disease process. In our recent studies, analyses of the prefrontal cortex of subjects with schizophrenia and matched controls uncovered complex changes in the expression of genes related to presynaptic secretory release, GABAergic and glutamatergic transmission, metabolic pathways, myelination, as well as cAMP and phosphoinositol second messenger systems. Our goal will be to integrate this expression data within the context of the relevant anatomical, biochemical, molecular, imaging and clinical findings.

Entities:  

Mesh:

Year:  2002        PMID: 12462404     DOI: 10.1023/a:1020904821237

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  116 in total

1.  TOGA: an automated parsing technology for analyzing expression of nearly all genes.

Authors:  J G Sutcliffe; P E Foye; M G Erlander; B S Hilbush; L J Bodzin; J T Durham; K W Hasel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

Review 2.  Divergence of RGS proteins: evidence for the existence of six mammalian RGS subfamilies.

Authors:  B Zheng; L De Vries; M Gist Farquhar
Journal:  Trends Biochem Sci       Date:  1999-11       Impact factor: 13.807

Review 3.  RGS proteins: more than just GAPs for heterotrimeric G proteins.

Authors:  L De Vries; M Gist Farquhar
Journal:  Trends Cell Biol       Date:  1999-04       Impact factor: 20.808

4.  A comparison of microarray databases.

Authors:  M Gardiner-Garden; T G Littlejohn
Journal:  Brief Bioinform       Date:  2001-05       Impact factor: 11.622

5.  Gene expression analysis in N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mice model of Parkinson's disease using cDNA microarray: effect of R-apomorphine.

Authors:  E Grünblatt; S Mandel; G Maor; M B Youdim
Journal:  J Neurochem       Date:  2001-07       Impact factor: 5.372

Review 6.  Molecular interactions on microarrays.

Authors:  E Southern; K Mir; M Shchepinov
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

7.  CYP2D6 genotyping with oligonucleotide microarrays and nortriptyline concentrations in geriatric depression.

Authors:  G M Murphy; B G Pollock; M A Kirshner; N Pascoe; W Cheuk; B H Mulsant; C F Reynolds
Journal:  Neuropsychopharmacology       Date:  2001-11       Impact factor: 7.853

8.  Olanzapine increases weight and serum triglyceride levels.

Authors:  D N Osser; D M Najarian; R L Dufresne
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

9.  An electron microscopic study of the types and proportions of neurons in the cortex of the motor and visual areas of the cat and rat.

Authors:  D A Winfield; K C Gatter; T P Powell
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

Review 10.  Long-term treatment of mood disorders in schizophrenia.

Authors:  J M Azorin
Journal:  Acta Psychiatr Scand Suppl       Date:  1995
View more
  33 in total

1.  Mining microarrays for metabolic meaning: nutritional regulation of hypothalamic gene expression.

Authors:  Charles V Mobbs; Kelvin Yen; Jason Mastaitis; Ha Nguyen; Elizabeth Watson; Elisa Wurmbach; Stuart C Sealfon; Andrew Brooks; Stephen R J Salton
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 2.  Functional genomics and proteomics: application in neurosciences.

Authors:  K E Wilson; M M Ryan; J E Prime; D P Pashby; P R Orange; G O'Beirne; J G Whateley; S Bahn; C M Morris
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

3.  Effects of developmental lead exposure on the hippocampal transcriptome: influences of sex, developmental period, and lead exposure level.

Authors:  Jay S Schneider; David W Anderson; Keyur Talsania; William Mettil; Rajanikanth Vadigepalli
Journal:  Toxicol Sci       Date:  2012-05-28       Impact factor: 4.849

Review 4.  Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain.

Authors:  Sergio E Baranzini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

5.  Microarray and real-time PCR analyses of gene expression in the honeybee brain following caffeine treatment.

Authors:  Robert Kucharski; Ryszard Maleszka
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

Review 6.  Molecular profiling of antipsychotic drug function: convergent mechanisms in the pathology and treatment of psychiatric disorders.

Authors:  Elizabeth A Thomas
Journal:  Mol Neurobiol       Date:  2006-10       Impact factor: 5.590

7.  Transcriptional signatures of cellular plasticity in mice lacking the alpha1 subunit of GABAA receptors.

Authors:  Igor Ponomarev; Rajani Maiya; Mark T Harnett; Gwen L Schafer; Andrey E Ryabinin; Yuri A Blednov; Hitoshi Morikawa; Stephen L Boehm; Gregg E Homanics; Ari E Berman; Ari Berman; Kerrie H Lodowski; Susan E Bergeson; R Adron Harris
Journal:  J Neurosci       Date:  2006-05-24       Impact factor: 6.167

Review 8.  Potential microbial origins of schizophrenia and their treatments.

Authors:  S Hossein Fatemi
Journal:  Drugs Today (Barc)       Date:  2009-04       Impact factor: 2.245

Review 9.  Gene expression profiling of the brain: pondering facts and fiction.

Authors:  Amanda C Mitchell; Károly Mirnics
Journal:  Neurobiol Dis       Date:  2011-06-14       Impact factor: 5.996

Review 10.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.